metabolic disorders 4 Flashcards

1
Q

Describe Familial Hypercholesterolaemia (FH)

A

FH is an autosomal dominant disease characterized by high levels of total serum cholesterol, particularly in homozygotes (>900 mg/dL). It is associated with high LDL levels and normal HDL levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Do individuals with Homozygous FH have a high risk of coronary heart disease (CHD

A

Yes, individuals with Homozygous FH have a high mortality rate from CHD the age of 30, with an increased risk of myocardial infarction () at 56 years of age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define LDLR in the context of FH

A

LDLR stands for low-density lipoprotein receptor and is the most common defect associated with Familial Hypercholesterolaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does Hypercholesterolaemia impact the risk of CHD/AMI in individuals without a genetic defect?

A

Hypercholesterolaemia is a major risk factor for CHD/AMI even in individuals without a genetic defect, emphasizing the importance of cholesterol management.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the reasons why screening for FH is not recommended by the UK National Screening Committee

A

The lack of evidence on the effectiveness of childhood screening, uncertainty about reducing illness or death from FH, unanswered questions about universal screening, and the general lack of awareness among GPs are key reasons for not recommending screening.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe atherosclerosis.

A

A disease of large/medium arteries characterized by the accumulation of LDL in the vessel wall, leading to the formation of ‘foam cells’ and plaques with a fibrous cap, which can rupture and cause thrombosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the role of LDL in atherosclerosis?

A

LDL accumulates in the vessel wall, where it is taken up by macrophages to form ‘foam cells’ and contributes to the formation of plaques.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define xanthoma.

A

A condition characterized by the accumulation of cholesterol in tissues, leading to yellowish nodules in areas such as the skin of hands, elbows, knees, and around the cornea of the eye.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How did the discovery of the LDL receptor impact our understanding of familial hypercholesterolemia (FH)?

A

The discovery of the LDL receptor by Goldstein and Brown in the 1970s revealed that mutations in the LDL receptor were responsible for FH, as cells from patients with FH could not take up LDL, leading to increased plasma LDL/cholesterol levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the role of LDLR in cholesterol metabolism.

A

LDLR is a major regulator of circulating LDL/cholesterol levels, as its loss leads to increased plasma LDL/cholesterol levels due to reduced uptake of LDL by the liver and peripheral tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the main types of lipoprotein particles involved in cholesterol and triglyceride transport?

A

The main types are chylomicrons, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does LDL contribute to cholesterol transport in the body?

A

LDL plays a role in cholesterol transport by carrying cholesterol esters to various tissues, where it is taken up by cells through the LDL receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the composition and function of low-density lipoprotein (LDL).

A

LDL consists of a single apoprotein component, ApoB-100, which acts as the ligand for the LDL receptor and is responsible for transporting cholesterol to tissues by interacting with the LDLR in the liver and peripheral tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the role of LDL in the formation of foam cells in the vessel wall.

A

LDL leads to an increase in circulating LDL, which further increases levels in the vessel wall and promotes foam cell formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the major drug therapy for familial hypercholesterolemia?

A

Statin drugs, specifically HMG-CoA reductase inhibitors, are the major drug therapy for familial hypercholesterolemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define the term ‘reverse cholesterol transport’ in lipoprotein metabolism.

A

Reverse cholesterol transport refers to the process where HDL transports cholesterol back to the liver from peripheral tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do statins work in lowering LDL levels in the body?

A

Statins work by inhibiting HMG-CoA reductase, which leads to lower cholesterol biosynthesis, reduced secretion of cholesterol, increased expression of LDLR, and ultimately lower LDL levels in circulation.

18
Q

Describe the relationship between cholesterol levels and the expression of LDLR.

A

Cholesterol downregulates HMG-CoA reductase by proteolysis, which in turn decreases LDLR expression.

19
Q

What is the primary cause of elevated LDL-cholesterol in familial hypercholesterolemia?

A

Elevated LDL-cholesterol in familial hypercholesterolemia is primarily due to mutations in LDLR.

20
Q

Do statins effectively treat homozygous familial hypercholesterolemia?

A

Statins are not effective in treating homozygous familial hypercholesterolemia.

21
Q

Define the term ‘chylomicron remnants’ in lipoprotein metabolism.

A

Chylomicron remnants are the remnants left after much of the triglyceride is removed from chylomicrons in circulation.

22
Q

How do competitive inhibitors of HMG-CoA reductase relate to the product mevalonate?

A

Competitive inhibitors of HMG-CoA reductase are structurally related to the product mevalonate.

23
Q

Describe the process of conversion of VLDL to LDL in the liver.

A

VLDL secreted from the liver is gradually converted to LDL by the removal of triglycerides.

24
Q

What is the major site of regulation in cholesterol metabolism involving HMG-CoA reductase?

A

HMG-CoA reductase is the major site of regulation in cholesterol metabolism.

25
Q

How does the liver respond to low cholesterol levels in the body?

A

The liver responds to low cholesterol levels by increasing the expression of LDLR, leading to more LDL being cleared from circulation and further lowering LDL levels.

26
Q

Describe the role of scavenger receptors in the formation of foam cells.

A

Scavenger receptors, different from LDLR, are responsible for the formation of foam cells in the vessel wall.

27
Q

What is the significance of LDL levels in the risk of cardiovascular disease according to epidemiological studies?

A

There is an exponential increase in the risk of cardiovascular disease with increased LDL levels, as shown in various epidemiological studies.

28
Q

Do statins have a controversial role in primary prevention of cardiovascular disease?

A

Statins are also used in primary prevention of cardiovascular disease, a practice that is considered controversial.

29
Q

Define the term ‘good cholesterol’ in lipoprotein metabolism.

A

HDL is often referred to as ‘good cholesterol’ in the context of lipoprotein metabolism.

30
Q

How does cholesterol affect the expression of HMG-CoA reductase in the body?

A

Cholesterol downregulates HMG-CoA reductase by proteolysis.

31
Q

Describe the process of LDL transport in the body.

A

LDL is transported to peripheral tissues or returned to the liver after being converted from VLDL.

32
Q

What is the major function of chylomicrons in lipid transport?

A

Chylomicrons transport lipids from the intestine to the liver.

33
Q

How does cholesterol metabolism differ in familial hypercholesterolemia compared to non-genetic hypercholesterolemia?

A

In familial hypercholesterolemia, LDLR mutations account for over 60% of genetic defects, leading to dysregulated lipoprotein metabolism.

34
Q

Describe the process of cholesterol biosynthesis inhibition by statins.

A

Statins inhibit the pathway of cholesterol biosynthesis by targeting HMG-CoA reductase.

35
Q

What is the role of LDL in the formation of foam cells in the vessel wall?

A

LDL leads to an increase in circulating LDL, which further increases levels in the vessel wall and promotes foam cell formation.

36
Q

How do statins lower LDL levels in the body?

A

Statins work by inhibiting HMG-CoA reductase, leading to lower cholesterol biosynthesis, reduced secretion of cholesterol, increased expression of LDLR, and ultimately lower LDL levels in circulation.

37
Q

Describe the relationship between cholesterol levels and LDLR expression.

A

Cholesterol downregulates HMG-CoA reductase by proteolysis, which in turn decreases LDLR expression.

38
Q

What is the primary treatment for familial hypercholesterolemia?

A

The primary treatment for familial hypercholesterolemia is the lowering of LDL levels, often achieved through the use of statins.

39
Q

Define the term ‘chylomicron remnants’ in lipid transport.

A

Chylomicron remnants are the remnants left after much of the triglyceride is removed from chylomicrons in circulation.

40
Q

How are competitive inhibitors of HMG-CoA reductase related to the product mevalonate?

A

Competitive inhibitors of HMG-CoA reductase are structurally related to the product mevalonate.